CWC
REGN icon

Carolinas Wealth Consulting’s Regeneron Pharmaceuticals REGN Stock Holding History

Carolinas Wealth Consulting’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-42
Closed -$26.6K – 735
2025
Q1 		$26.6K Buy
42
+1
+2% +$688 0.01% 423
2024
Q4 		$29.2K Sell
41
-8
-16% -$6.71K 0.01% 427
2024
Q3 		$51.5K Buy
49
+2
+4% +$2.23K 0.01% 361
2024
Q2 		$49.4K Sell
47
-2
-4% -$1.94K 0.01% 368
2024
Q1 		$47.2K Buy
49
+1
+2% +$951 0.01% 386
2023
Q4 		$42.2K Hold
48
– – 0.01% 360
2023
Q3 		$37.4K Sell
48
-4
-8% -$3.14K 0.01% 348
2023
Q2 		$37.4K Sell
52
-16
-24% -$12.3K 0.01% 393
2023
Q1 		$55.9K Sell
68
-10
-13% -$7.54K 0.01% 338
2022
Q4 		$56.3K Hold
78
– – 0.01% 331
2022
Q3 		$54K Buy
78
+22
+39% +$13.8K 0.01% 316
2022
Q2 		$33K Hold
56
– – 0.01% 381
2022
Q1 		$39K Sell
56
-1
-2% -$633 0.01% 383
2021
Q4 		$36K Hold
57
– – 0.01% 411
2021
Q3 		$34K Buy
57
+1
+2% +$621 0.01% 396
2021
Q2 		$31K Sell
56
-1
-2% -$507 0.01% 429
2021
Q1 		$27K Hold
57
– – 0.01% 460
2020
Q4 		$28K Hold
57
– – 0.01% 425
2020
Q3 		$32K Buy
57
+22
+63% +$13.3K 0.01% 345
2020
Q2 		$22K Buy
+35
New +$19.9K 0.01% 279

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carolinas Wealth Consulting's REGN Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 42 shares — an estimated $26.6K sold.

Carolinas Wealth Consulting first reported a position in REGN in Q2 2020 and held it in 20 quarters. The position peaked at $56.3K in Q4 2022. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 42 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $26.6K.
  • Carolinas Wealth Consulting first reported a position in Regeneron Pharmaceuticals in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's Regeneron Pharmaceuticals position peaked at $56.3K in Q4 2022.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.